74,307 Shares in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Acquired by Acuta Capital Partners LLC
MarketBeat
Acuta Capital Partners LLC purchased a new position in shares of Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 74,307 shares of the company's stock, valued at approximately $398,000. Acuta Ca
NASDAQ:CRVS